SC
KZR

Shay Capital’s Kezar Life Sciences KZR Stock Holding History

Shay Capital’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33,699
Closed -$212K – 572
2025
Q4 		$212K Sell
33,699
-33,962
-50% -$198K 0.02% 410
2025
Q3 		$264K Hold
67,661
– – 0.02% 322
2025
Q2 		$310K Buy
67,661
+150
+0.2% +$643 0.04% 221
2025
Q1 		$329K Buy
67,511
+8,353
+14% +$50.7K 0.05% 188
2024
Q4 		$398K Buy
+59,158
New +$441K 0.06% 202

Other funds holding KZR

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Shay Capital's KZR Position: Q1 2026 in Review

Shay Capital sold out of Kezar Life Sciences (KZR) in Q1 2026, closing a stake of 33,699 shares — an estimated $212K sold.

Shay Capital first reported a position in KZR in Q4 2024 and held it in 5 quarters. The position peaked at $398K in Q4 2024. 43 funds tracked by Wall St. Rank hold KZR as of Q1 2026.

  • Shay Capital reported no remaining Kezar Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Shay Capital sold 33,699 Kezar Life Sciences shares in Q1 2026, an estimated $212K.
  • Shay Capital first reported a position in Kezar Life Sciences in Q4 2024 and held it in 5 quarters.
  • Shay Capital's Kezar Life Sciences position peaked at $398K in Q4 2024.
  • 43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2026.

Based on Shay Capital's 13F filing for Q1 2026, filed 15 May 2026.